A previous report showed an increase of APLP1β28 relative to the total amount of APLP1 peptides in CSF from AD subjects [28] while we recently showed that the levels of APLP1β25, 1β27 and 1β28 in CSF from Down’s syndrome patients are decreased as compared to healthy controls [36]. Here, APLP1 is linked to Alzheimer disease.